Effectiveness of a Clinical Decision Support System for Reducing the Risk of QT Interval Prolongation in Hospitalized Patients (vol 7, pg 381, 2014)

被引：0
|
作者：
Tisdale
机构：
来源：
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES | 2014年 / 7卷 / 06期
关键词：
D O I：
10.1161/HCQ.0000000000000009
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：981 / 981
页数：1
相关论文
共 50 条
  • [1] Effectiveness of a Clinical Decision Support System for Reducing the Risk of QT Interval Prolongation in Hospitalized Patients
    Tisdale, James E.
    Jaynes, Heather A.
    Kingery, Joanna R.
    Overholser, Brian R.
    Mourad, Noha A.
    Trujillo, Tate N.
    Kovacs, Richard J.
    [J]. CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2014, 7 (03): : 381 - 390
  • [2] EFFECTIVENESS OF A CLINICAL DECISION SUPPORT SYSTEM INCORPORATING A VALIDATED QT INTERVAL PROLONGATION RISK SCORE FOR REDUCING THE RISK OF QT INTERVAL PROLONGATION IN HOSPITALIZED PATIENTS
    Tisdale, James
    Wroblewski, Heather
    Kingery, Joanna
    Overholser, Brian
    Trujillo, Tate N.
    Kovacs, Richard
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 59 (13) : E1799 - E1799
  • [3] A RISK SCORE TO PREDICT QT INTERVAL PROLONGATION IN HOSPITALIZED PATIENTS
    Tisdale, James
    Wroblewski, Heather A.
    Kingery, Joanna R.
    Trujillo, Tate N.
    Overholser, Brian R.
    Kovacs, Richard J.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 57 (14) : E112 - E112
  • [4] Development and Validation of a Risk Score to Predict QT Interval Prolongation in Hospitalized Patients (vol 6, pg 479, 2013)
    Tisdale
    [J]. CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2013, 6 (06): : E57 - E57
  • [5] Implementation of a clinical decision support system to guide appropriate medication use and monitoring in hospitalized patients with drug-induced QT interval prolongation
    Khoa Truong
    Blackford, Anthony
    Hoppes, Justin
    Odeh, Adam
    Patterson, Tricia
    Schneck, Stephanie
    [J]. PHARMACOTHERAPY, 2017, 37 (12): : E219 - E219
  • [6] Development and Validation of a Risk Score to Predict QT Interval Prolongation in Hospitalized Patients
    Tisdale, James E.
    Jaynes, Heather A.
    Kingery, Joanna R.
    Mourad, Noha A.
    Trujillo, Tate N.
    Overholser, Brian R.
    Kovacs, Richard J.
    [J]. CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2013, 6 (04): : 479 - 487
  • [7] An introduction to QT interval prolongation and non-clinical approaches to assessing and reducing risk
    Pollard, C. E.
    Abi Gerges, N.
    Bridgland-Taylor, M. H.
    Easter, A.
    Hammond, T. G.
    Valentin, J-P
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2010, 159 (01) : 12 - 21
  • [8] The effect of intravenous haloperidol on QT interval dispersion in critically ill patients: Comparison with QT interval prolongation for assessment of risk of Torsades de Pointes (vol 41, pg 1310, 2001)
    Tisdale, JE
    Rasty, S
    Padhi, ID
    Sharma, ND
    Rosman, H
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 42 (05): : 577 - 579
  • [9] Decision Support System Detecting Patients at Risk of Prolonged QT and Associated Mortality
    Caraballo, Pedro J.
    Bos, Johan M.
    Qian, Ray
    Fischer, Karen M.
    Johnsen, Paul J.
    Schreie, Diana J.
    Simon, Gyorgy
    Ackerman, Michael J.
    [J]. MEDINFO 2023 - THE FUTURE IS ACCESSIBLE, 2024, 310 : 1378 - 1379
  • [10] Clozapine blood concentration predicts corrected QT-interval prolongation in patients with psychoses (vol 42, pg 536, 2022)
    不详
    [J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2023, 43 (03) : 304 - 304
12345